Gunderson Dettmer Stough Villeneuve Franklin & Hachigian represented Colossal Biosciences in the transaction. Colossal Biosciences, the world’s first de-extinction company, announced it raised $200 million in...
Colossal Biosciences’ $200 Million Series C Financing Round
Edwards Lifesciences’ Acquisition of JenaValve
Gunderson Dettmer Stough Villeneuve Franklin & Hachigian represented JenaValve Technology in the transaction. Involved fees earner: Heather Aune – Gunderson Dettmer Stough Villeneuve Franklin & Hachigian;...
Veradigm’s $140 Million Acquisition of ScienceIO
McDermott Will & Emery represented Veradigm Inc. in the transaction, and Gunderson Dettmer Stough Villeneuve Franklin & Hachigian represented ScienceIO. Veradigm Inc. (NASDAQ: MDRX) (the “Company”),...